drugset / Trial / NCT03843502
A Phased Clinical Trial of Dietary Supplemental Kava: Kava Pharmacokinetics
Phase 1
Completed
10 enrolled
University of Florida
National Center for Complementary and Integrative Health (NCCIH) · collabThorne HealthTech, Inc · collab
NaSingle-groupOpen-labelBasic science
Summary
Kava is a dietary supplement on the US market and is experiencing a resurgence of its use. Its pharmacokinetic information, however, is lacking which is important for its future effective usage as a dietary supplement or potentially as a botanical therapeutics. This phased trial, based on the recommendation from NIH, is to collect pharmacokinetic data of kava in healthy subjects.
Timeline
- Start
- 2020-02-26
- Primary completion
- 2021-04-21
- Completion
- 2021-07-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Kava | Unknown | 75 mg | — |
Indications
No indication recorded.